Filter
194
Filtered Results: 194
Text search:
National
Pharmacovigilance
and
Medicines
Information
Center
Featured
Recommendations
25
New Publications
59
Language
Document type
No document type
109
Guidelines
30
Studies & Reports
29
Manuals
11
Strategic & Response Plan
7
Training Material
3
Situation Updates
3
Fact sheets
2
Countries / Regions
Rwanda
10
Nigeria
10
Kenya
9
Ethiopia
9
Namibia
8
India
8
Ghana
7
South Africa
6
Nepal
5
Cambodia
5
Liberia
5
Philippines
4
Latin America and the Carribbean
4
Tanzania
4
Eastern Europe
4
Zambia
4
Mozambique
3
Western and Central Europe
3
Russia
3
Ukraine
2
Sierra Leone
2
Malawi
2
Africa
2
Asia
2
West and Central Africa
2
South–East Asia Region
2
Bangladesh
2
Uganda
2
Botswana
2
Indonesia
2
Pakistan
2
Thailand
1
Lesotho
1
Gambia
1
Cameroon
1
Laos
1
Senegal
1
Afghanistan
1
Zimbabwe
1
Haiti
1
Jordan
1
Middle East and North Africa
1
Western Pacific Region
1
East and Southern Africa
1
Argentina
1
Sri Lanka
1
Georgia
1
Libya
1
Bhutan
1
Myanmar / Burma
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Drugs & Medical Equipment
34
Policies & Guidelines HIV & TB
28
Policies
26
Guidelines
17
Studies & Reports
9
NTDs & Others
6
TB
5
Statistics
4
Pharmacy & Technology
3
Communicable Diseases
2
Vaccine-preventable Diseases
2
Pharmaceutical Assessments
2
NCD
2
Women & Child Health
2
Capacity Building
2
General Guidelines
2
Leprosy
2
Helminthiasis
1
Trachoma
1
Taeniasis/ Cysticercosis
1
Onchocerciasis
1
Schistosomiasis
1
Dermatology
1
Lymphaticfilariasis
1
Cancer
1
COVID-19
1
Pediatric cancer
1
Snakebites
1
Pediatrics
1
Countries
1
Medical Devices & Equipment
1
Clinical Guidelines
1
Respiratory Infections
1
Immunization
1
Health Systems
1
Primary Health Care
1
Non-communicable Diseases
1
Malaria
1
Disease Prevention & Control
1
Key Resources
1
Toolboxes
Country specific
7
Rational use of Medicine
7
Immunization Guidelines
6
Clinical Guidelines
5
Supporting tools
4
Hospital Readiness/Essential Health Services
4
Traditional & Herbal Medicines
4
Pharmacovigilance
4
Clinical Aspects, Treatment & Prevention
3
Country Specific
3
Pharmacy Practice
3
General Guidelines for Rational Use
3
Drug resistant TB
3
Antiretroviral Treatment ART
3
Treatment & Prevention
2
Adults
2
Ethiopia
2
Studies
2
General
2
Infection Control General
2
Access & Strategy
2
Essential Medicines
2
Falsified & Substandard
2
Pharmaceutical Assessments
2
Reports & Studies
2
Eastern Europe & Central Asia
2
Kenya
2
Reports & Studies
2
SEAR (South-east Asia Region)
2
Eastern Europe and central Asia
2
Clinical Guidelines
1
Clinical Aspects
1
Prevention & Control
1
Vaccination
1
Children & Adolescents
1
WPRO (Western Pacific Region)
1
Influenza
1
Namibia
1
HIV
1
Rwanda
1
TB & Other Vulnerable Populations
1
Children
1
Georgia
1
Drug resistance
1
Country Guidelines
1
International
1
Prevention & Preparedness
1
Context & Facts, Travel Advice
1
Surveillance & Contact tracing
1
Training, others
1
Gender Aspects
1
Oxygen Therapy
1
TB/HIV
1
Logistics & Supply
1
Fair Allocation & Ethical Aspects
1
COVAX Initiative
1
Biontech/Pfizer Comirnaty
1
Research & Pipeline
1
General documents One Health
1
Antimicrobial Resistance (AMR)
1
Non-communicable Diseases NCD
1
Heat
1
Capacity Building & Resources
1
Studies & Reports
1
Patient Safety
1
Overview, Studies & Reports
1
Clinical Aspects & Diagnosis
1
Diagnosis
1
Romania
1
Asia and Pacific
1
Co-Morbidities (except TB)
1
General Aspects
1
Regional Reports & Guidelines, others
1
Education of students & professionals
1
Research & Access
1
General Public
1
Clinical Guidelines
1
HIV service delivery
1
AmR (Region of Americas)
1
TB
1
Preparedness & Prevention
1
Treatment & Clinical Management
1
The prevalence, availability, and use of antimalarial medicines (AMLs) were studied in six Cambodian provinces along the Thai-Cambodian border. The study was divided into two parts: the first looked at the quality of AMLs available in Pursat, Pailin, Battambang, Bantey Meanchey, Oddar Meanchey, and ...
This Indicator-Based Pharmacovigilance Assessment Tool (IPAT) was developed as a comprehensive performance metric for pharmacovigilance and medicine safety systems.
The document contains a set of indicators that can be used for monitoring traditional and complementary medicine (T&CM) systems in a country.
The core indicator set consists of 16 indicators that were considered essential and collectively able to provide information on T&CM inputs, processes and ou...
PQM conducted an assessment of the medicine quality assurance and quality control systems in Rwanda during November 9-13, 2009. Medicine quality assurance remains to be developed in Rwanda: the country has neither a medicine regulatory authority (MRA) nor a national medicine quality control laborato...
The purpose of these guidelines is to help health workers to participate in the process of continuous surveillance of safety and efficacy of the pharmaceutical products which are used in clinical practice, thus help to achieve the ultimate goal to make safer and more effective treatment available to...
These guidelines for the National Pharmacovigilance and Medicine Information System in Rwanda have been developed to ensure that safe, efficacious and quality medicines are made available to all Rwandans.
Therapeutics Information and Pharmacovigilance Centre | TIPC
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
Accessed November, 2017
The Libyan national action plan has been aligned with WHO five objectives. Analysis of the current situation and addressing the gaps and the needs to reach the main goal “one health” approach involves several national sectors and actors, including human and veterinary health, agriculture and foo...
The Federal Ministry of Health (FMOH) has been coordinating sector wide reforms that aim to improve equity and quality of health services. It is widely known that; the sector is growing in line the overall growth and transformation plan of the country and the sector is bein...
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis, ...
The PHC STGs and EML should be used by healthcare workers providing care at clinics, community health centres, and gateway clinics at hospitals.
Pharmaceutical and Therapeutics Committees (PTCs) are responsible for ensuring the availability of medicines listed in the PHC EML at those facilities, as...
This document seeks to help health communication professionals working on the topic of immunization more effectively communicate about Events Supposedly Attributed to Vaccination and Immunization (ESAVI) by building trust in National Immunization Programs, understanding risk perceptions related to v...
The "Primary Healthcare Standard Treatment Guidelines and Essential Medicines List" by the South African National Department of Health provides evidence-based guidelines for diagnosing and managing common medical conditions at the primary healthcare level. This document includes treatment protocols ...
